Why I’d still buy and hold this FTSE 250 dividend stock forever

G A Chester explains why major merger news hasn’t changed his positive view on this FTSE 250 (INDEXFTSE:MCX) dividend stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

“Our favourite holding period is forever” is one of many famous quotes of legendary investor Warren Buffett. However, he’s also stressed it’s not a “commitment”. Things can and do change that can shorten his holding period, sometimes considerably.

I’ve long been bullish on real estate company Primary Health Properties (LSE: PHP). Back in the summer of 2017, I named it as a stock I’d buy and hold forever. And as recently as December, it was one of my three top FTSE 250 dividend picks for 2019 and beyond.

However, on 24 January, the company made an announcement of significant importance for its future. It said it had agreed an all-share merger with fellow healthcare property firm MedicX. Under the terms of the merger, existing shareholders of PHP would hold 69.4% and MedicX shareholders 30.6% of the enlarged group.

Now, a little less than a year ago, I wrote rather scathingly of a similar proposed all-share merger in the real estate sector between retail property groups Hammerson and Intu. Should I be equally negative about PHP’s deal with MedicX, or do I still see it as a stock to buy and hold forever?

Strategic rationale

One of reasons I was unimpressed by Hammerson’s proposed deal was that the company had been strategically reducing its exposure to the UK in favour of Europe. Its acquisition of Intu would have represented an inexplicable and unwise U-turn, in my view, significantly upping its exposure to the UK.

As a contrast, PHP’s proposed acquisition of MedicX is entirely consistent with its existing strategy. And the two companies’ portfolios are highly complementary.

Balance sheet matters

Intu’s elevated debt would have markedly weakened Hammerson’s financial position. Indeed, the company anticipated embarking on a disposal programme of at least £2bn, in order to strengthen its balance sheet and provide liquidity to reinvest in higher return opportunities. Finding buyers for £2bn+ of less-than-prime assets in a challenging retail property market didn’t sound a particularly straightforward matter to me.

PHP’s acquisition of MedicX has a less material impact on the strength of its balance sheet. And there’s no mention of any planned asset disposals post-merger.

Cost savings and financing optimisation

I criticised Hammerson’s deal for its relatively low quantified cost savings, and reckoned potential optimisation of the enlarged group’s borrowing arrangements was the primary attraction. I think PHP’s deal is similar on this score, although I calculate its quantified costs savings — pound for pound — are a little better than those Hammerson had hoped to realise.

Still positive

Under pressure from some of its major shareholders, Hammerson’s board ultimately backed out of the deal with Intu. But I believe shareholders of PHP will back their board, that MedicX’s shareholders will also likely be supportive, and that the deal will go ahead.

I view it favourably myself, for the relatively positive reasons discussed. In addition, execution risk appears limited, with the unification of property management under PHP’s existing property manager being the main source of the quantified cost synergies.

Operating in an area of the real estate market in which the income stream is particularly secure and predictable, PHP looks more than capable of extending its record of 22 years of annual dividend increases. At a share price of 116p, with a prospective yield of 4.8%, it remains a stock I’d be happy to buy today and hold ‘forever’.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »